Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.84
Delayed Data
As of Feb 12
 +0.46 / +5.49%
Today’s Change
6.06
Today|||52-Week Range
15.79
-33.58%
Year-to-Date
No recent news for Lexicon Pharmaceuticals Inc.

Today’s Trading

Previous close8.38
Today’s open8.44
Day’s range8.21 - 8.88
Volume606,332
Average volume (3 months)803,344
Market cap$916.0M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+5.00%
Earnings growth (this year)+3.76%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)+928.53%
P/E ratioNM
Price/Sales21.28
Price/Book3.22

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc-0.57-3.91%
ARIAARIAD Pharmaceutical...+0.24+5.36%
EXELExelixis Inc0.000.00%
FGENFibroGen Inc+0.51+2.97%
Data as of 4:14pm ET, 02/12/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$22.9M
Annual profit (last year)-$100.3M
Net profit margin-438.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
VP-Marketing, Commercial Strategy &
Operations
John Northcott
Corporate headquarters
The Woodlands, Texas

Forecasts

Partner Offers